Company Filing History:
Years Active: 2016
Title: Teresa Tse Ki Man: Innovator in mGlu2 Receptor Agonists
Introduction
Teresa Tse Ki Man is a prominent inventor based in Middlesex, GB. She has made significant contributions to the field of pharmacology, particularly in the development of novel compounds for mental health treatment. Her work focuses on mGlu2 receptor agonists, which have potential applications in treating various psychiatric disorders.
Latest Patents
Teresa holds 1 patent for her invention titled "Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mGlu2 receptor agonist." This innovative patent presents novel mGlu2 agonists that are useful in the treatment of bipolar disorder, schizophrenia, and generalized anxiety disorder. Her research aims to provide new therapeutic options for patients suffering from these conditions.
Career Highlights
Teresa is currently employed at Eli Lilly and Company, a leading global pharmaceutical company. Her role involves extensive research and development in the area of mental health medications. Through her work, she has contributed to advancing the understanding of mGlu2 receptor functions and their implications in psychiatric disorders.
Collaborations
Some of Teresa's notable coworkers include James Allen Monn and Carlos Montero Salgado. Their collaborative efforts have further enhanced the research and development of innovative treatments in the pharmaceutical industry.
Conclusion
Teresa Tse Ki Man is a dedicated inventor whose work in mGlu2 receptor agonists holds promise for improving mental health treatments. Her contributions to the field are significant and reflect her commitment to advancing medical science.